Mrs Carrie Jo Williamson, LPN | |
9445 Bell Rd, Adamsville, OH 43802-9756 | |
(740) 221-0379 | |
Not Available |
Full Name | Mrs Carrie Jo Williamson |
---|---|
Gender | Female |
Speciality | Licensed Vocational Nurse |
Location | 9445 Bell Rd, Adamsville, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689851727 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164X00000X | Licensed Vocational Nurse | 123624 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Carrie Jo Williamson, LPN 9445 Bell Rd, Adamsville, OH 43802-9756 Ph: (740) 221-0379 | Mrs Carrie Jo Williamson, LPN 9445 Bell Rd, Adamsville, OH 43802-9756 Ph: (740) 221-0379 |
News Archive
Chronic Obstructive Pulmonary Disease is much more common among never smoking older women who are morbidly obese (having a body mass index of 40 or higher) than among their female peers in the normal weight range (13.4% vs 3.5%, respectively).
Carine Chen-McLaughlin, coordinator of Case Management Operations at Sinai Hospital of Baltimore, has been selected as one of 50 Social Work Heroes for Justice by the University of Maryland School of Social Work.
Effective coaching can lead to smoothly functioning organizations, better productivity and potentially more profit. In classrooms, better student performance can occur. Doctors or nurses can connect more with patients. So, doing coaching right would seem to be a natural goal, and it has been a major topic of research at Case Western Reserve University's Weatherhead School of Management since 1990.
Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.
› Verified 1 days ago